Is radiomic MRI a feasible alternative to OncotypeDX® recurrence score testing? A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2021 at "BJS Open"
DOI: 10.1093/bjsopen/zrab081
Abstract: Abstract Background OncotypeDX® recurrence score (RS) aids therapeutic decision-making in oestrogen-receptor-positive (ER+) breast cancer. Radiomics is an evolving field that aims to examine the relationship between radiological features and the underlying genomic landscape of disease… read more here.
Keywords: less versus; systematic review; cent; per cent ... See more keywords